REVIEW
Published on 15 May 2026
Functionalized nanomedicines for co-targeting of multiple pathways to efficiently treat thyroid cancer: prospects and challenges
doi 10.3389/fphar.2026.1796656
- 504 views
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Nanomedicine in Cancer Therapy: Advances and Challenges
Nanomedicine in Cancer Therapy: Advances and Challenges
1,157
Total downloads
8,826
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 01 May 2026
Tat-HSPE1 suppresses clear cell renal cell carcinoma growth through lysosome-dependent cell death
doi 10.3389/fphar.2026.1822208
- 386 views
REVIEW
Published on 29 Apr 2026
Physicochemical design of nanobiomaterials in oncology: structure-to-function principles for sequential transport and delivery
doi 10.3389/fonc.2026.1817437
- 388 views
REVIEW
Published on 20 Apr 2026
Biomedical applications and perspectives of two-dimensional porphyrin-based MOFs
doi 10.3389/fphar.2026.1819283
- 464 views
ORIGINAL RESEARCH
Published on 03 Mar 2026
Double-edged-sword effect of bisphosphonates on the osteogenic differentiation of human periodontal ligament stem cells
doi 10.3389/fphar.2026.1752252
- 334 views
ORIGINAL RESEARCH
Published on 26 Feb 2026
Extracellular vesicles delivering TIMP-2 modulate MMP-1, MMP-2, and MMP-9 expression in human lung adenocarcinoma A549 cells
doi 10.3389/fphar.2026.1784404
- 416 views
ORIGINAL RESEARCH
Published on 08 Dec 2025
Human fibrosarcoma cells selected for ultra-high doxorubicin resistance, acquire trabectedin cross-resistance, remain sensitive to recombinant methioninase, and have increased c-MYC expression
doi 10.3389/fonc.2025.1704021
- 1,242 views
- 1 citation
MINI REVIEW
Published on 28 Oct 2025
PLGA-based nanoparticles in colorectal cancer immunotherapy: current concepts and future perspectives
doi 10.3389/fphar.2025.1714460
- 2,297 views
- 6 citations
Published in
Frontiers in Oncology
Pharmacology of Anti-Cancer Drugs
Other participating journals
Frontiers in Pharmacology
- 4.8 impact factor
- 8.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: